FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/06/019768 [Registered on: 19/06/2019] Trial Registered Prospectively
Last Modified On: 18/06/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparision of two anaesthetic regimens intravenous (propofol-fentanyl) and inhalation (sevoflurane-fentanyl) in intraoperative and postoperative effects in brain tumor surgery 
Scientific Title of Study   Comparision of two anaesthetic regimens(Propofol-fentanyl)versus(sevoflurane-fentanyl) on perioperative haemodynamics,operating conditions and immediate postoperative outcomes in patients undergoing elective neurosurgical procedures involving brain tumors 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sashmita kumari Padhy 
Designation  senior resident (DM)neuroanaesthesia 
Affiliation  SCTIMST TRIVANDRUM 
Address  Division of neuroanaesthesia,Neurosurgery OT,4th floor
Division of neuroanaesthesia,Neurosurgery OT,4th floor
Thiruvananthapuram
KERALA
695011
India 
Phone  7873216296  
Fax    
Email  padhysmi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manikandan S 
Designation  proffessor and head of division of neuroanaesthesia 
Affiliation  SCTIMST TRIVANDRUM 
Address  Srichitra Tirunal institute of medical science and technology,Trivandrum
SCTIMST,Trivandrum
Thiruvananthapuram
KERALA
695011
India 
Phone  9446334711  
Fax    
Email  kanmanis@sctimst.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sashmita kumari Padhy 
Designation  senior resident (DM)neuroanaesthesia 
Affiliation  SCTIMST TRIVANDRUM 
Address  division of neuroanaesthesia,neurosurgery OT,4th floor
division of neuroanaesthesia,neurosurgery OT,4th floor
Thiruvananthapuram
KERALA
695011
India 
Phone  7873216296  
Fax    
Email  padhysmi@gmail.com  
 
Source of Monetary or Material Support  
Sree Chitra Tirunql Institute For Medical Sciences And Technology, Trivandrum 
 
Primary Sponsor  
Name  Dr Sashmita kumari padhy 
Address  Senior Resident Sree Chitra Tirunql Institute For Medical Sciences And Technology, Trivandrum 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
Nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sashmita Kumari Padhy  SCTIMST  Division of neuroanaesthesia,neurosurgery OT,4th floor
Thiruvananthapuram
KERALA 
7873216296

padhysmi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ECR/189/Inst/KL/2013  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G93||Other disorders of brain,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  group 1 patient will get titrated cincentration of sevoflurane end tidal and MAC value titrated to keep BIS 45 to 50  group 1 patient will get titrated cincentration of sevoflurane end tidal and MAC value titrated to keep BIS 45 to 50 
Intervention  Group 1 patients will be given titrared sevoflurane to keep BIS value 45 to 50  Sevoflurane vaporiser dial concentration titrated according to BIS value between 45-50 and end tidal sevoflurane and MAC value of sevoflurane monitored.recovery profile ,intraop brain relaxtation will be compared with propofol group 
Comparator Agent  group 2 patients will get titrated dose of propofol infusion to keep BIS 45 to 50  effect site concentration of propofol calculated through TCI pump schneider model,titrated to keep BIS 45 to 50 
Intervention  Group 2 patients will be given titrated dose of propofol infusion to keep BIS value 45 to 50  Propofol infusion will be given through target control infusion pump,effect site concentration through schneider model calculated,effect site concentration of propofol will be titrated to maintain BIS value 45 to 50.introp brain relaxttion,recovery profile and haemodynamics compared with group 1 patients  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  patients undergoing elective neurosurgeries for primary brain tumors of age between 18 to 60 years,of either sex, ASA 1 and 2, GCS 14-15 
 
ExclusionCriteria 
Details  patients with cardiac disease,uncontrolled hypertension,uncontrolled dibetic,COPD,hepatic and renal dysfunction,age less than 18 years,more than 60 years,GCS less than 13,ASA 3 and 4,recurrent tumors,patient who had surgery related complication like vascular injury,massive bleeding,injury to vital structre requiring postop ventillatory support,obese patient 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Brain relaxtation ,recovery from anaesthesia like time to eye opening,time to obey commands ,time to extubation after discontinuation of anaesthesia,intraoperative haemodynamics,post extubation haemodynamics  Time taken for eye opening,to obey verbal command ,time for extubation after discontinuation of anaesthesia noted,brain relaxtation assesed by neurosurgeon at time of bone reflection,dural reflection,tumor ressection,dural closure assesesd,haemodynamics preop,preinduction,intubation,pinning,postpinning,skin incision,15 min interval till dural closure,at durl closure,subcutaneous tissue,skin,declamping,preextubation,extubation and immediately after extubation upto 1 hour 
 
Secondary Outcome  
Outcome  TimePoints 
postop side effects pain,PONV,shivering,agitation,convulsion,desaturation.total opoid consumption,total propofol consumption,any bolus dose of propofol and amount,effect site concentration of propofol during induction,intraop period,sevoflurane end tidal concentation and MAC value during intraop period  intraoperative period upto 24 hours after extubation 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   20/06/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="1" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
This is a prospective,randomised  double blind single center  study .Eligible patients with brain tumor will be administered written informed consent prior to enrollment in study.Patients will be randomised to receive either propofol-fentanyl group or sevoflurane - fentanyl group for maintainence of anaesthesia. Group 1 patients will get sevoflurane for maintainence of anaesthesia.Sevoflurane concentration end tidal value and MAC value titrated to maintain BIS between 45 to 50.Fentanyl infusion 1mcg/kg/hr continued upto starting of closure of subcutaneous tissue in both the groups.Group 2 patients will get propofol infusion for maintainence of anaesthesia.propofol effect site concentration calculated through schneider model  TCI pump,effect site concentration titrated to maintain BIS 45 to 50. Anaesthesia discontinued at end of skin closure.Intraoperative brain relaxtation  will be assesed by 4 point scale at the time of bone deflection,dural reflection,tumor ressection and dural closure. Haemodynamics  will be recorded pre operative period,pre induction ,intubation,post intubation,pinning,post pinning,skin incision,15 minute interval till dural closure,closure of dura,subcutaneous tissue,skin closure,declamping of pin,extubation and immediately after extubation upto 1hour recorded. total fentanyl used during surgery,sevoflurane end tidal concentration,MAC value ,effect site concentration of propofol , any bolus dose of propofol,total propofol consumption,Side effects like nausea,vomitting,shivering,pain (assessed by VAS  upto 6 hours of extubation),desaturation,delerium or agitation ,covulsion will be observed  and any treatment to be recorded.
 
Close